Clinical trial · Observational
Genetic Susceptibility to Kidney Cancer
Genetic Susceptibility to Renal Cell Carcinoma
NCT00854022CI-TRIAL-00043606terminatedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Funding ended
Summary
Brief summary (as posted)
This study will further the understanding of the genetic events leading to the development of RCC.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Renal Cell Carcinoma | Renal Cell Carcinoma | CURATED_BROADER | 0.80 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (2)
- label
- Healthy
- description
- Healthy adults, of any ethnicity, or sex, and with no previous history of cancer, except for non-melanoma skin cancer
- label
- RCC
- description
- Adult patients with newly diagnosed (diagnosed within the year of enrollment) renal carcinoma (RCC) any ethnicity, or sex, who have not received prior chemotherapy or radiotherapy.
Primary outcomes (1)
- measure
- To identify interindividual differences in inherited genetic instability
- timeFrame
- 12 months
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Adult patients of any ethnicity or sex, who have a been diagnosed with possible Renal Cell Carcinoma within the past year. Exclusion Criteria: * Must not have received chemotherapy, biological therapy or radiation therapy in the 6 months preceding enrollment will * Must not have had RCC, or metastatic RCC, * Must not have had a renal transplantation
References
Publications (0)
Data not yet available
No reference posted for this study.